BIOPSY FORCEPS FB-52C-1Recalls & reported problems
Olympus Medical Systems Corp. · FB-52C-1 BIOP FRCPS FENES RAT T ALLG RU · Class 2
All models of BIOPSY FORCEPS (18)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04953170030529), received between Jul 21, 2022 and Jul 21, 2022 — classified as 1 injury.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- Hemorrhage/Blood Loss/Bleeding1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryJul 21, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
OLYMPUS REVIEWED THE FOLLOWING LITERATURE TITLED "DOES CRYOPROBE BIOPSY INCREASE THE DIAGNOSTIC YIELD IN ENDOBRONCHIAL TUMOR LESIONS?". THE AIM WAS TO COMPARE THE FLEXIBLE CRYOPROBE WITH CONVENTIONAL FORCEPS BIOPSY (FB) REGARDING DIAGNOSTIC YIELD, AND TO SHOW THE FEASIBILITY, SAFETY, AND POSSIBLE COMPLICATIONS IN PATIENTS WITH ENDOBRONCHIAL TUMOR LESIONS. A TOTAL OF 40 PATIENTS WITH ENDOSCOPICALLY VISIBLE LESIONS WERE RANDOMIZED INTO TWO GROUPS: GROUP I INCLUDED 20 PATIENTS IN WHOM BIOPSIES WERE CARRIED OUT USING FB (TWO SAMPLES) AND GROUP II INCLUDED 20 PATIENTS IN WHOM BIOPSIES WERE CARRIED OUT USING CRYOBIOPSY (CB) (ONE SAMPLE). THERE WAS HIGHER SIGNIFICANT DIAGNOSTIC YIELD OF CB AS REGARDS THE DIAMETER SIZE, FINALLY DIAGNOSED TYPE OF LUNG CANCER AND THAT WAS DIAGNOSED FROM THE FIRST TIME BRONCHOSCOPY OR AFTER REDOBROCHOSCOPY THAN FB. BLEEDING WAS THE ONLY DETECTED COMPLICATION DURING BOTH PROCEDURES, BUT THERE WERE NO STATISTICALLY SIGNIFICANT DIFFERENCE AMONG BOTH TECHNIQUES AS REGARDS BLEEDING DURING PROCEDURE, NEED FOR HEMOSTATICS DURING THE PROCEDURE, HEMOPTYSIS POSTPROCEDURE OR NEED FOR HEMOSTATICS POSTPROCEDURE. ENDOBRONCHIAL CB IS A SAFE, SUCCESSFUL, AND CONFIDENT TECHNI
Patient problems: Hemorrhage/Blood Loss/Bleeding
MAUDE report 15078275 ↗
Other BRONCHOSCOPE (FLEXIBLE OR RIGID) devices
- EVIS EXERA III BRONCHOVIDEOSCOPE OLYMPUS BF-1TH190Olympus Medical Systems Corp. · BRONCHOSCOPE (FLEXIBLE OR RIGID)3 recalls5 deaths1,557 reports
- EVIS EXERA III BRONCHOVIDEOSCOPE OLYMPUS BF-H190Olympus Medical Systems Corp. · BRONCHOSCOPE (FLEXIBLE OR RIGID)4 recalls1 death1,214 reports
- EVIS EXERA III BRONCHOVIDEOSCOPE OLYMPUS BF-XP190Olympus Medical Systems Corp. · BRONCHOSCOPE (FLEXIBLE OR RIGID)4 recalls1,146 reports
- Ion 380748Intuitive Surgical, Inc. · Bronchoscope (flexible or rigid)1 recall97 deaths1,278 reports
- VISERA ELITE XENON LIGHT SOURCE OLYMPUS CLV-S190Olympus Medical Systems Corp. · BRONCHOSCOPE (FLEXIBLE OR RIGID)1,155 reports
- EVIS EXERA III BRONCHOVIDEOSCOPE OLYMPUS BF-P190Olympus Medical Systems Corp. · BRONCHOSCOPE (FLEXIBLE OR RIGID)5 recalls3 deaths621 reports
- EVIS EXERA III BRONCHOVIDEOSCOPE OLYMPUS BF-1TH190Olympus Medical Systems Corp. · Bronchoscope (Flexible Or Rigid)3 recalls333 reports
- BRONCHOVIDEOSCOPE BF-1T150Olympus Medical Systems Corp. · BRONCHOSCOPE (FLEXIBLE OR RIGID)4 recalls212 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page